Shanghai Model Organisms Center Inc (688265) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.009x

Based on the latest financial reports, Shanghai Model Organisms Center Inc (688265) has a cash flow conversion efficiency ratio of 0.009x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥15.97 Million ≈ $2.34 Million USD) by net assets (CN¥1.70 Billion ≈ $249.07 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Shanghai Model Organisms Center Inc (688265) defensive interval to measure how many days the company can operate on defensive assets alone.

Shanghai Model Organisms Center Inc - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how Shanghai Model Organisms Center Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai Model Organisms Center Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai Model Organisms Center Inc ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Barings Corporate Investors
NYSE:MCI
0.013x
Gladstone Land Corporation
NASDAQ:LAND
0.016x
Zhongyan Technology Co Ltd
SHE:003001
0.048x
Wabash National Corporation
NYSE:WNC
-0.105x
Biglari Holdings Inc
NYSE:BH-A
0.039x
Dongbu Steel Co Ltd
KO:016380
0.053x
Kernex Microsystems (India) Limited
NSE:KERNEX
-0.178x
Metrodata Electronics Tbk
JK:MTDL
-0.162x

Annual Cash Flow Conversion Efficiency for Shanghai Model Organisms Center Inc (2015–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai Model Organisms Center Inc from 2015 to 2025. For the full company profile with market capitalisation and key ratios, see Shanghai Model Organisms Center Inc market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥1.71 Billion
≈ $250.11 Million
CN¥96.92 Million
≈ $14.18 Million
0.057x +33.36%
2024-12-31 CN¥1.68 Billion
≈ $246.28 Million
CN¥71.56 Million
≈ $10.47 Million
0.043x +267.74%
2023-12-31 CN¥1.74 Billion
≈ $254.15 Million
CN¥20.08 Million
≈ $2.94 Million
0.012x +8.08%
2022-12-31 CN¥1.77 Billion
≈ $258.41 Million
CN¥18.89 Million
≈ $2.76 Million
0.011x -82.88%
2021-12-31 CN¥1.78 Billion
≈ $261.01 Million
CN¥111.46 Million
≈ $16.31 Million
0.062x -73.05%
2020-12-31 CN¥254.93 Million
≈ $37.30 Million
CN¥59.10 Million
≈ $8.65 Million
0.232x -9.74%
2019-12-31 CN¥135.38 Million
≈ $19.81 Million
CN¥34.77 Million
≈ $5.09 Million
0.257x +145.19%
2018-12-31 CN¥112.13 Million
≈ $16.41 Million
CN¥11.75 Million
≈ $1.72 Million
0.105x +23.43%
2017-12-31 CN¥97.02 Million
≈ $14.20 Million
CN¥8.23 Million
≈ $1.20 Million
0.085x -67.69%
2016-12-31 CN¥98.35 Million
≈ $14.39 Million
CN¥25.83 Million
≈ $3.78 Million
0.263x -20.05%
2015-12-31 CN¥62.18 Million
≈ $9.10 Million
CN¥20.43 Million
≈ $2.99 Million
0.329x --

About Shanghai Model Organisms Center Inc

SHG:688265 China Biotechnology
Market Cap
$363.36 Million
CN¥2.48 Billion CNY
Market Cap Rank
#13990 Global
#4185 in China
Share Price
CN¥31.85
Change (1 day)
+2.28%
52-Week Range
CN¥28.41 - CN¥72.54
All Time High
CN¥73.40
About

Shanghai Model Organisms Center, Inc. engages research and development, production, sale, and related technical services of genetically modified animal models. The company uses model organisms, such as mice, rats, zebrafish, and nematodes as carriers which uses gene editing technology to introduce or delete target DNA fragments. It offers toolbox of mice; disease mice, such as rare, infectious, a… Read more